{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:05Z","timestamp":1792783145772,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Thailand Science research and Innovation Fund Chulalongkorn University","award":["HEA_FF_69_125_3300_016"],"award-info":[{"award-number":["HEA_FF_69_125_3300_016"]}],"id":[{"id":"https:\/\/ror.org\/028wp3y58","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"DOI":"10.1007\/s11095-026-04206-0","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:57:27Z","timestamp":1790193447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Predictive Performance of Machine Learning and Population Pharmacokinetic Models for Valproic Acid Clearance and Trough Concentrations: An In-silico Simulation Study in Epilepsy Scenarios"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-8769","authenticated-orcid":false,"given":"Janthima","family":"Methaneethorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-3171","authenticated-orcid":false,"given":"Supavadee","family":"Aramvith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6864-9066","authenticated-orcid":false,"given":"Khanita","family":"Duangchaemkarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1310-1495","authenticated-orcid":false,"given":"Brad","family":"Reisfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"2","key":"4206_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"CU Johannessen","year":"2003","unstructured":"Johannessen CU, Johannessen SI. Valproate: past, present, and future. CNS Drug Rev. 2003;9(2):199\u2013216.","journal-title":"CNS Drug Rev"},{"issue":"1","key":"4206_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","volume":"22","author":"LC Johannessen","year":"2008","unstructured":"Johannessen LC. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22(1):27\u201347.","journal-title":"CNS Drugs"},{"issue":"3","key":"4206_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cnr.2004.09.013","volume":"4","author":"DC Lagace","year":"2004","unstructured":"Lagace DC, Timothy O\u2019Brien W, Gurvich N, Nachtigal MW, Klein PS. Valproic acid: how it works. Or not. Clin Neurosci Res. 2004;4(3):215\u201325.","journal-title":"Clin Neurosci Res"},{"key":"4206_CR4","volume-title":"Winter's basic clinical pharmacokinetics","author":"P Beringer","year":"2023","unstructured":"Beringer P. Winter\u2019s basic clinical pharmacokinetics. Wolters Kluwer Health; 2023."},{"issue":"5","key":"4206_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"J Methaneethorn","year":"2018","unstructured":"Methaneethorn J. A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol. 2018;84(5):816\u201334.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"4206_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","volume":"61","author":"E Perucca","year":"2006","unstructured":"Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61(3):246\u201355.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"4206_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Y Ghodke-Puranik","year":"2013","unstructured":"Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2013;23(4):236\u201341.","journal-title":"Pharmacogenet Genomics"},{"key":"4206_CR8","volume-title":"Clinical pharmacokinetics","author":"JE Murphy","year":"2011","unstructured":"Murphy JE. Clinical pharmacokinetics. ASHP; 2011."},{"key":"4206_CR9","doi-asserted-by":"crossref","unstructured":"Silva MF, Aires CC, Luis PB, Ruiter JP, L IJ, Duran M, et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis. 2008;31(2):205\u201316.","DOI":"10.1007\/s10545-008-0841-x"},{"issue":"3","key":"4206_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/157015910792246254","volume":"8","author":"SI Johannessen","year":"2010","unstructured":"Johannessen SI, Landmark CJ. Antiepileptic drug interactions - principles and clinical implications. Curr Neuropharmacol. 2010;8(3):254\u201367.","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"4206_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, et al. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49(7):1239\u201376.","journal-title":"Epilepsia"},{"key":"4206_CR12","doi-asserted-by":"crossref","unstructured":"Tong Dominic MH, Hughes Maria-Stephanie A, Hu J, Pearson Jeffrey C, Kubiak David W, Dionne Brandon W, et al. Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis. Antimicrobial Agents Chemother. 2025;69(2):e01040\u201324.","DOI":"10.1128\/aac.01040-24"},{"issue":"6","key":"4206_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/bcp.12276","volume":"77","author":"N Kassir","year":"2014","unstructured":"Kassir N, Labb\u00e9 L, Delaloye JR, Mouksassi MS, Lapeyraque AL, Alvarez F, et al. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients. Br J Clin Pharmacol. 2014;77(6):1051\u201363.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"4206_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s40262-025-01547-8","volume":"64","author":"J Methaneethorn","year":"2025","unstructured":"Methaneethorn J, Duangchaemkarn K, Reisfeld B, Habiballah S. Methodological techniques used in machine learning to support individualized drug dosing regimens based on pharmacokinetic data: a scoping review. Clin Pharmacokinet. 2025;64(9):1295\u2013330.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"4206_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00228-025-03874-y","volume":"81","author":"J Chen","year":"2025","unstructured":"Chen J, Wang J, Li K, Wu Y, Wang Z, Guo J, et al. Dosing prediction of valproic acid in pediatric patients with epilepsy: population pharmacokinetic model or machine learning model? Eur J Clin Pharmacol. 2025;81(9):1333\u201341.","journal-title":"Eur J Clin Pharmacol"},{"key":"4206_CR16","doi-asserted-by":"publisher","first-page":"1521932","DOI":"10.3389\/fphar.2024.1521932","volume":"15","author":"YW Chen","year":"2024","unstructured":"Chen YW, Lin XK, Chen S, Zhang YL, Wu W, Huang C, et al. Monitoring of the trough concentration of valproic acid in pediatric epilepsy patients: a machine learning-based ensemble model. Front Pharmacol. 2024;15:1521932.","journal-title":"Front Pharmacol"},{"issue":"10","key":"4206_CR17","doi-asserted-by":"publisher","first-page":"e70353","DOI":"10.1111\/cts.70353","volume":"18","author":"TK Chung","year":"2025","unstructured":"Chung TK, Lee H. A comparison of AI and population PK models to predict the concentrations of antiepileptic drugs using therapeutic drug monitoring records. Clin Transl Sci. 2025;18(10):e70353.","journal-title":"Clin Transl Sci"},{"key":"4206_CR18","doi-asserted-by":"publisher","first-page":"890221","DOI":"10.3389\/fphar.2022.890221","volume":"13","author":"P Zheng","year":"2022","unstructured":"Zheng P, Yu Z, Mo L, Zhang Y, Lyu C, Yu Y, et al. An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques. Front Pharmacol. 2022;13:890221.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4206_CR19","doi-asserted-by":"publisher","first-page":"e0049925","DOI":"10.1128\/spectrum.00499-25","volume":"13","author":"K Chen","year":"2025","unstructured":"Chen K, Wang C, Wei Y, Ma S, Huang W, Dong Y, et al. Machine learning and population pharmacokinetics: a hybrid approach for optimizing vancomycin therapy in sepsis patients. Microbiol Spectr. 2025;13(5):e0049925.","journal-title":"Microbiol Spectr"},{"key":"4206_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jad.2023.11.047","volume":"347","author":"C-W Hsu","year":"2024","unstructured":"Hsu C-W, Lai EC-C, Chen Y-CB, Kao H-Y. Valproic acid monitoring: serum prediction using a machine learning framework from multicenter real-world data. J Affect Disord. 2024;347:85\u201391.","journal-title":"J Affect Disord"},{"key":"4206_CR21","doi-asserted-by":"publisher","first-page":"106876","DOI":"10.1016\/j.ejps.2024.106876","volume":"201","author":"P Ma","year":"2024","unstructured":"Ma P, Shang S, Huang Y, Liu R, Yu H, Zhou F, et al. Joint use of population pharmacokinetics and machine learning for prediction of valproic acid plasma concentration in elderly epileptic patients. Eur J Pharm Sci. 2024;201:106876.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"4206_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(SICI)1099-081X(199907)20:5<233::AID-BDD179>3.0.CO;2-5","volume":"20","author":"B Blanco-Serrano","year":"1999","unstructured":"Blanco-Serrano B, Otero MJ, Santos-Buelga D, Garc\u00eda-S\u00e1nchez MJ, Serrano J, Dom\u00ednguez-Gil A. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data. Biopharm Drug Dispos. 1999;20(5):233\u201340.","journal-title":"Biopharm Drug Dispos"},{"issue":"8","key":"4206_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.2042-7158.1997.tb06106.x","volume":"49","author":"E Yukawa","year":"1997","unstructured":"Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T. Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening. J Pharm Pharmacol. 1997;49(8):751\u20136.","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"4206_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/cpt1977216736","volume":"21","author":"U Klotz","year":"1977","unstructured":"Klotz U, Antonin KH. Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther. 1977;21(6):736\u201343.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"4206_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/BF03261928","volume":"51","author":"TKL Kiang","year":"2012","unstructured":"Kiang TKL, Sherwin CMT, Spigarelli MG, Ensom MHH. Fundamentals of population pharmacokinetic modelling. Clin Pharmacokinet. 2012;51(8):515\u201325.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"4206_CR26","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/bcp.14801","volume":"88","author":"M McComb","year":"2022","unstructured":"McComb M, Bies R, Ramanathan M. Machine learning in pharmacometrics: opportunities and challenges. Br J Clin Pharmacol. 2022;88(4):1482\u201399.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"4206_CR27","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla AV, Schmitt V, Maier CS, Mensing S, Stodtmann S. Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development. Clin Transl Sci. 2024;17(11):e70056.","journal-title":"Clin Transl Sci"},{"issue":"3","key":"4206_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2125.1989.tb05372.x","volume":"27","author":"SK Panesar","year":"1989","unstructured":"Panesar SK, Orr JM, Farrell K, Burton RW, Kassahun K, Abbott FS. The effect of carbamazepine on valproic acid disposition in adult volunteers. Br J Clin Pharmacol. 1989;27(3):323\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"4206_CR29","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s40262-025-01564-7","volume":"64","author":"K Irie","year":"2025","unstructured":"Irie K, Minar P, Reifenberg J, Boyle BM, Noe JD, Hyams JS, et al. Hybrid population pharmacokinetic-machine learning modeling to predict infliximab pharmacokinetics in pediatric and young adult patients with Crohn\u2019s disease. Clin Pharmacokinet. 2025;64(11):1669\u201379.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"4206_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/cpt.3049","volume":"115","author":"QY Li","year":"2024","unstructured":"Li QY, Tang BH, Wu YE, Yao BF, Zhang W, Zheng Y, et al. Machine learning: a new approach for dose individualization. Clin Pharmacol Ther. 2024;115(4):727\u201344.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04206-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:57:28Z","timestamp":1790193448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04206-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":30,"alternative-id":["4206"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04206-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflict of interest was reported by the authors.","order":1,"name":"Ethics","label":"Disclosure Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"QuillBot\u00ae was used for grammar checking and correction. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}